Nurix Therapeutics Inc (NRIX) earnings · rev $84.0M
These earnings events as JSON? API free 100/dayNurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
This NRIX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported NRIX revenue for 2025-11-30 was $84.0M. Net income was -$264.5M. Revenue was up 54.0% from 2024-11-30 to 2025-11-30. NRIX currently screens at market cap $1.77B.
When the next NRIX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 54.0% from 2024-11-30 to 2025-11-30. An earnings headline that ignores that move is noise.
Not investment advice. Full NRIX research stays on the stock page; the tape stays on the quote page.
NRIX earnings FAQ
What are NRIX's latest revenue and net income?
Latest cached Nurix Therapeutics Inc (NRIX) revenue for Nov 30, 2025 was $84.0M. Net income was -$264.5M. Statements: https://lician.com/financials/nrix
What is NRIX's latest diluted EPS?
Latest cached Nurix Therapeutics Inc (NRIX) diluted EPS for Nov 30, 2025 was -$3.05.
What period does the latest NRIX earnings print cover?
The latest cached Nurix Therapeutics Inc (NRIX) earnings print covers Nov 30, 2025. The prior cached period on this page is Nov 30, 2024.
How did NRIX revenue change from the prior cached period?
Cached Nurix Therapeutics Inc (NRIX) revenue was up 54.0% from $54.5M (Nov 30, 2024) to $84.0M (Nov 30, 2025). Statements: https://lician.com/financials/nrix
Where are NRIX earnings listed?
Cached earnings facts for Nurix Therapeutics Inc (NRIX) are listed at https://lician.com/earnings/nrix. Statements: https://lician.com/financials/nrix
Not investment advice.